QUALITY HEALTHCARE MANAGEMENT INC
NPI 1194744185, organization, Brooklyn, NY, Clinical Medical Laboratory
- Listed on the KY Medicaid exclusion list since October 7, 2023.
- Medicaid still paid claims in 14 later months, $1,092,507 in total.
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| KY Medicaid exclusion list state list extracted from https://chfs.ky.gov/agencies/dms/dpi/pe/documents/kymedicaidterminationlist.xlsx (pandas claude colmap) | Exact NPI, name verified | Oct 7, 2023 | still open | 14 | Nov 2023 | Dec 2024 | $1.1M | $2.5M |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | QUALITY HEALTHCARE MANAGEMENT INC (also QUALITY LABORATORY SERVICE; QUALITY LABORATORY SERVICES) |
| Type | Organization |
| Status | Active |
| NPI issued | July 19, 2006, last updated August 11, 2023 |
| Practice location | 2651 E 14TH ST, Brooklyn, NY 11235-3915, 718-646-5100 |
| Authorized official | Alexander Kharaz (Chief Operating Officer) |
| Specialties | Clinical Medical Laboratory (291U00000X, primary, license 33D1018138 NY) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $2.0M | 9% | $143 | $146 (top 5% from $318) | 49th percentile | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $1.8M | 8% | $55 | $77 (top 5% from $218) | 23rd percentile | |
| 80307 | Testing for presence of drug, by chemistry analyzers | $1.2M | 5% | $17 | $45 (top 5% from $110) | 19th percentile | |
| 82306 | Vitamin d-3 level | $790K | 4% | $16 | $20 (top 5% from $40) | 41st percentile | |
| 80364 | Medicaid service code | $498K | 2% | $8.39 | $11 (top 5% from $32) | 41st percentile | |
| 80348 | Medicaid service code | $438K | 2% | $7.44 | $10 (top 5% from $29) | 35th percentile | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $421K | 2% | $187 | $133 (top 5% from $245) | 82nd percentile | |
| 86481 | Tuberculosis test, enumeration of t-cells | $396K | 2% | $30 | $53 (top 5% from $99) | 27th percentile |
| code | what it is | services | beneficiaries | paid | submitted per service | allowed per service | charge to allowed | usual for this code |
|---|---|---|---|---|---|---|---|---|
| 82306 | Vitamin d-3 level | 13,130 | 7,885 | $381K | $165 | $29 | 5.7x | 2.9x (90th percentile 5.3x) |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 17,760 | 9,990 | $292K | $98 | $16 | 5.9x | 3.3x (90th percentile 5.5x) |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 18,964 | 10,703 | $249K | $76 | $13 | 5.8x | 3.5x (90th percentile 6.9x) |
| 80053 | Blood test, comprehensive group of blood chemicals | 22,850 | 11,540 | $236K | $60 | $10 | 5.8x | 3.7x (90th percentile 7.4x) |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 10,733 | 4,007 | $221K | $21 | $21 | 1.0x | 1.0x (90th percentile 2.3x) |
| 82607 | Cyanocobalamin (vitamin b-12) level | 14,556 | 8,455 | $215K | $83 | $15 | 5.6x | 3.4x (90th percentile 5.5x) |
| 82746 | Folic acid level, serum | 13,324 | 7,735 | $192K | $76 | $14 | 5.3x | 3.2x (90th percentile 5.5x) |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 1,275 | 1,128 | $178K | $496 | $140 | 3.6x | 1.6x (90th percentile 3.2x) |
A submitted charge many times the allowed amount is common and lawful; it matters when it is far above what other providers submit for the same code.
In this area
133 providers in Kings County, NY carry an indicator in the public record, with $470.7M at stake between them. The most common is more hours than a day holds, on 108 of them, followed by named in an enforcement record on 12. 10 are tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | FAST LAB TECHNOLOGIES LLC Brooklyn, NY, ranked 8 | $4K |
|
| 1 | FAMILY SOCIAL ADULT DAY CARE Brooklyn, NY, ranked 49 | $2.4M |
|
| 1 | DM OPTICAL INC Brooklyn, NY, ranked 60 | $1.2M |
|
| 1 | PRIME LIFE ADULT DAY CARE LLC Brooklyn, NY, ranked 70 | $837K |
|
| 1 | COMPREHENSIVE MEDICAL DIAGNOSTIC, PC Brooklyn, NY, ranked 145 | $105K |
|
| 1 | MODERN MEDICAL TESTING, P.C. Brooklyn, NY, ranked 146 | $104K |
|
| 1 | JOHN YIU Brooklyn, NY, ranked 193 | $48K |
|
| 1 | ROBERT VACCARINO Brooklyn, NY, ranked 376 | $2K |
|
Recent enforcement in NY
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.